Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 8Other hematologic neoplasm 2Lymphoid 2Gastrointestinal 2CNS 2Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 264Leukemia, Lymphocytic, Chronic, B-Cell 249Leukemia, Myeloid, Acute 236Leukemia 235Lymphoma 177Lymphoma, Non-Hodgkin 168Lymphoma, Follicular 154Burkitt Lymphoma 146Lymphoma, Large B-Cell, Diffuse 142Lymphoma, B-Cell, Marginal Zone 135Lymphoma, Mantle-Cell 133Lymphoma, Large-Cell, Immunoblastic 115Hodgkin Disease 109Myelodysplastic Syndromes 107Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 96Congenital Abnormalities 90Multiple Myeloma 86Lymphoma, T-Cell, Cutaneous 81Lymphoma, Large-Cell, Anaplastic 76Hematologic Neoplasms 75Leukemia, Myelomonocytic, Chronic 74Waldenstrom Macroglobulinemia 73Immunoblastic Lymphadenopathy 70Leukemia, Myelomonocytic, Acute 69Sezary Syndrome 68Mycosis Fungoides 68Blast Crisis 68Leukemia, Monocytic, Acute 62Myeloproliferative Disorders 61Leukemia, Myelogenous, Chronic, BCR-ABL Positive 61

Interventions

tanespimycin 1ganitumab 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Desmoplastic Small Round Cell Tumor × Other hematologic neoplasm × Clear all
NCT00562380 2013-07-18

AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
64 enrolled
DermatologicGenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Prostatic Neoplasms, Sarcoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Neuroectodermal Tumors, Primitive, Peripheral, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Desmoplastic Small Round Cell Tumor

NCT00093821 2013-06-04

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
70 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Neuroblastoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡